Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy Combined With Adebrelimab, Bevacizumab, and Platinum in TNBC Brain Metastases
NCT07638852Phase 2Recruiting
- Sponsor
- Fudan University
- Start
- Feb 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 2 trial of adebrelimab in triple-negative breast cancer (TNBC), sponsored by Fudan University. Started Feb 2026; status: recruiting.
02
Drugs
adebrelimab
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT07638852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07638852.